These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2494150)

  • 21. [Clinical use of the dexamethasone suppression test].
    De Leo D; Capodieci S
    Minerva Psichiatr; 1984; 25(2):115-25. PubMed ID: 6436632
    [No Abstract]   [Full Text] [Related]  

  • 22. [Laboratory diagnosis of depressive disorders].
    Linkowski P
    Rev Med Brux; 1983 Apr; 4(4):229-33. PubMed ID: 6410481
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings.
    Rush AJ; Schlesser MA; Roffwarg HP; Giles DE; Orsulak PJ; Fairchild C
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):23-9. PubMed ID: 6409892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The dexamethasone suppression test and TRH stimulation test in endogenous depressives, schizophrenics, and normal volunteers].
    Ho SL; Lu RB; Ferng HK; Lin TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Apr; 41(4):271-80. PubMed ID: 3141027
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical, neuroendocrine, and sleep EEG diagnosis of "unusual" affective presentations: a practical review.
    Akiskal HS; Lemmi H
    Psychiatr Clin North Am; 1983 Mar; 6(1):69-83. PubMed ID: 6412218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bipolar illness, catatonia, and the dexamethasone suppression test in adolescence: case report.
    Hall DC; Ries RK
    J Clin Psychiatry; 1983 Jun; 44(6):222-4. PubMed ID: 6406474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical and biologic aspects of adolescent depression.
    Gourash L; Puig-Antich J
    Semin Adolesc Med; 1986 Dec; 2(4):299-310. PubMed ID: 3110894
    [No Abstract]   [Full Text] [Related]  

  • 28. Cerebral ventricular size in major depressive disorder: association with delusional symptoms.
    Targum SD; Rosen LN; DeLisi LE; Weinberger DR; Citrin CM
    Biol Psychiatry; 1983 Mar; 18(3):329-36. PubMed ID: 6404312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical correlates of the TRH infusion test in primary depression.
    Kirstein L; Gold MS; Extein I; Martin D; Pottash AL
    J Clin Psychiatry; 1982 May; 43(5):191-4. PubMed ID: 6804446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biological aspects of dysthymia].
    Poirier MF
    Encephale; 1994 Jun; 20 Spec No 2():257-60. PubMed ID: 7916287
    [No Abstract]   [Full Text] [Related]  

  • 31. [Neuroendocrinology of depressive disorders].
    Linkowski P; Mendlewicz J
    Sem Hop; 1982 Dec; 58(44):2589-95. PubMed ID: 6297052
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sleeping depression. Psychopathological and biochemical findings in a single case analysis].
    Erkwoh R
    Nervenarzt; 1986 Sep; 57(9):538-41. PubMed ID: 2876396
    [No Abstract]   [Full Text] [Related]  

  • 33. [Biologic markers and prediction of response to treatment in depression].
    Uytdenhoef P; Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1982; 82(3):229-42. PubMed ID: 6187184
    [No Abstract]   [Full Text] [Related]  

  • 34. [Nosographic classification of depressive syndromes and neuro-endocrine tests].
    Gay C; Combes A; Benkelfat C; Olié JP; Susini-De Luca H; Kameleddine F; Askienazy S; Lôo H
    Therapie; 1984; 39(3):209-20. PubMed ID: 6431628
    [No Abstract]   [Full Text] [Related]  

  • 35. Borderline disorders--the validity of the diagnostic concept.
    Dahl AA
    Psychiatr Dev; 1985; 3(2):109-52. PubMed ID: 3931071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depression and Parkinson's disease.
    Mayeux R; Stern Y; Williams JB; Sano M; Cote L
    Adv Neurol; 1987; 45():451-5. PubMed ID: 2435113
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of masked and endogenous depression using psychometric scales, endocrinological markers and pharmacological responses. Masked depression versus endogenous depression].
    Pinard G; Desmarais PA; Cormier H; Dymetryszyn R; Tétreault L
    Encephale; 1986; 12(3):99-103. PubMed ID: 3095093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous use of thyrotropin-releasing hormone test and combined dexamethasone/corticotropine-releasing hormone test for severity evaluation and outcome prediction in patients with major depressive disorder.
    Isogawa K; Nagayama H; Tsutsumi T; Kiyota A; Akiyoshi J; Hieda K
    J Psychiatr Res; 2005 Sep; 39(5):467-73. PubMed ID: 15992555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of bulimia with antidepressants: theoretical considerations and clinical findings.
    Hudson JI; Pope HG; Jonas JM
    Res Publ Assoc Res Nerv Ment Dis; 1984; 62():259-73. PubMed ID: 6420851
    [No Abstract]   [Full Text] [Related]  

  • 40. Biologic markers in borderline personality disorder: a review.
    Lahmeyer HW; Reynolds CF; Kupfer DJ; King R
    J Clin Psychiatry; 1989 Jun; 50(6):217-25. PubMed ID: 2498295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.